Cheminformatic Tools and Databases for Pharmacology

session 41164 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
REPOTRECTINIB

REPOTRECTINIB

ANTINEOPLASTIC
TREATMENT OF ROS1-POSITIVE NON-SMALL CELL LUNG CANCER
INHIBITOR OF PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS1 (ROS1) AND OF THE TROPOMYOSIN RECEPTOR TYROSINE KINASES (TRKS) TRKA, TRKB, AND TRKC

ORAL

Cmax 2 MICROMOLAR

Tmax 2.5 HOUR

F 45.7 PERCENT

VD 432 LITER

PPB 95.4 PERCENT

Cl 15.9 LITER / HOUR

HT 50.6 HOUR

TYROSINE-PROTEIN KINASE ROS1

PDB 7VKN (CRYSTAL STRUCTURE OF TRKA (G595R) KINASE WITH REPOTRECTINIB)

LIGAND CODE = 7GI (link to the list of PDB complexes)

Download experimental 3D coordinates of 7GI with added hydrogens

-

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |